DNMT2-m5C-ACLY Axis Promotes Lenvatinib Resistance in Hepatocellular Carcinoma Through Histone Acetylation-Mediated Notch Pathway. The gene discussed is TRDMT1; the disease is hepatocellular carcinoma.